Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jilin Cheng

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
American Journal of Translational Research|November 11, 2016
Human immunodeficiency virus (HIV) is highly associated with giant idiopathic esophageal ulcers in acquired immunodeficiency syndrome (AIDS) patientsBei Lv, Xin Cheng, Jackson Gao, et al.
Hepatology International|November 29, 2021
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosisXiaoning Wu, Jia Hong, Jialing Zhou, et al.
Hepatology International|January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapyXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 5, 2020
Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSMBingqiong Wang, Jialing Zhou, Xiaoning Wu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2017
On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosisShanshan Wu, Yuanyuan Kong, Hongxin Piao, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Yiwen Shi, Jialing Zhou, et al.
The American Journal of Gastroenterology|November 6, 2023
Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label TrialBingqiong Wang, Jialing Zhou, Xiaoning Wu, et al.
Journal of Viral Hepatitis|January 10, 2019
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavirYuanyuan Kong, Yameng Sun, Jialing Zhou, et al.
Gastrointestinal Endoscopy|October 17, 2022
Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter studyYifei Huang, Jia Li, Tianlei Zheng, et al.
Journal of Clinical and Translational Hepatology|January 10, 2020
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis BShan Shan, Hong You, Junqi Niu, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Translational Research|November 11, 2016
Human immunodeficiency virus (HIV) is highly associated with giant idiopathic esophageal ulcers in acquired immunodeficiency syndrome (AIDS) patientsBei Lv, Xin Cheng, Jackson Gao, et al.
Hepatology International|November 29, 2021
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosisXiaoning Wu, Jia Hong, Jialing Zhou, et al.
Hepatology International|January 18, 2021
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapyXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 5, 2020
Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSMBingqiong Wang, Jialing Zhou, Xiaoning Wu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 10, 2017
On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosisShanshan Wu, Yuanyuan Kong, Hongxin Piao, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Yiwen Shi, Jialing Zhou, et al.
The American Journal of Gastroenterology|November 6, 2023
Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label TrialBingqiong Wang, Jialing Zhou, Xiaoning Wu, et al.
Journal of Viral Hepatitis|January 10, 2019
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavirYuanyuan Kong, Yameng Sun, Jialing Zhou, et al.
Gastrointestinal Endoscopy|October 17, 2022
Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter studyYifei Huang, Jia Li, Tianlei Zheng, et al.
Journal of Clinical and Translational Hepatology|January 10, 2020
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis BShan Shan, Hong You, Junqi Niu, et al.
Pageof 4